A student asks a question at last year’s "Major Trends” seminar.
Event
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 3, 2014

Every year, MSK gives high school students and their teachers the opportunity to learn about cutting-edge biomedical research from our scientists.

RISE Program Clinical Director Debra Mangino discusses next steps with a patient.
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 31, 2014

The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment.

Pictured: Jorge Reis-Filho and Britta Weigelt
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, October 28, 2014

Genetic alterations linked to a rare salivary cancer could also shed light on more common malignancies.

Pictured: Pseudomonas aeruginosa
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, October 21, 2014

MSK researchers discover that the body senses and attacks harmful bacteria indirectly after the pathogens cause stress within the cells.

Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Monday, October 20, 2014

Medical oncologist Paul Sabbatini demystifies common misconceptions surrounding clinical trials.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Pictured: Scott Lowe
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, September 30, 2014

In taking a new approach to finding treatments for hepatocellular carcinoma, MSK scientists have uncovered a potential drug target for this highly aggressive cancer.

Pictured: Paul Sabbatini
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, September 24, 2014

Medical oncologist Paul Sabbatini sheds light on how phase I clinical trials are conducted at Memorial Sloan Kettering and how to determine whether patients may be eligible for one.

Pictured: Experimental Brain Tumor
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 18, 2014

Researchers have engineered a gene into therapeutic cells that allows them to turn off tumor growth if some of the cells become cancerous.

Pictured: Nematode Worm Embryo
Snapshot
By Jennifer Bell, PhD  |  Thursday, September 11, 2014

Stunning movies captured in the lab of computational biologist Zhirong Bao reveal how cells divide, grow, and move around, as in a carefully choreographed dance, during the development of a nematode worm embryo.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 4, 2014

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.

In the Clinic
By Jennifer Castoro, BA, Managing/Copy Editor  |  Thursday, September 4, 2014

Researchers have found that in a subset of women, consumption of soy could boost the expression of genes linked to breast cancer.

Pictured: Johanna Joyce
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Tuesday, August 19, 2014

A new study sheds light on what enables breast cancer cells to spread to the brain and presents a potential target for drugs.

In the Lab
By Jim Stallard, MA, Writer/Editor  |  Monday, August 11, 2014

Experimental pathologist Jorge Reis-Filho explains how tumor DNA obtained from the blood could lead to noninvasive — yet highly sensitive — ways of detecting and monitoring cancer in the body.

Center News

Stay Informed

Get the latest information about cancer care and research every month.